HR 1178 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Alpha-gal Allergen Inclusion Act
To amend the Federal Food, Drug, and Cosmetic Act to add alpha-gal to the definition of ``major food allergen''.
Summary
This bill amends the Federal Food, Drug, and Cosmetic Act to designate alpha-gal (galactose-alpha-1,3-galactose) as a major food allergen, requiring food manufacturers to label products containing alpha-gal similarly to how they label products containing peanuts, tree nuts, milk, and eggs. Alpha-gal is a sugar molecule found in certain animal products and red algae that can trigger allergic reactions in people with alpha-gal syndrome. The bill defines alpha-gal allergen to include ingredients derived from non-catarrhine primate mammals and red algae in the order Gigartinales, but excludes mammal-derived ingredients with no detectable alpha-gal above established limits. The labeling requirement takes effect 18 months after enactment, giving food manufacturers time to identify and relabel products containing alpha-gal. This makes alpha-gal allergen disclosure requirements consistent with other major food allergen labeling regulations.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
46 cosponsors
- Del. Moylan, James C. [R-GU-At Large] (R-GU)
- Del. Norton, Eleanor Holmes [D-DC-At Large] (D-DC)
- Del. Radewagen, Aumua Amata Coleman [R-AS-At Large] (R-AS)
- Rep. Babin, Brian [R-TX-36] (R-TX)
- Rep. Balderson, Troy [R-OH-12] (R-OH)
- Rep. Balint, Becca [D-VT-At Large] (D-VT)
- Rep. Bice, Stephanie I. [R-OK-5] (R-OK)
- Rep. Biggs, Sheri [R-SC-3] (R-SC)
- Rep. Bonamici, Suzanne [D-OR-1] (D-OR)
- Rep. Carter, Earl L. "Buddy" [R-GA-1] (R-GA)
- Rep. Carter, John R. [R-TX-31] (R-TX)
- Rep. Cherfilus-McCormick, Sheila [D-FL-20] (D-FL)
- Rep. Cleaver, Emanuel [D-MO-5] (D-MO)
- Rep. Cline, Ben [R-VA-6] (R-VA)
- Rep. Davids, Sharice [D-KS-3] (D-KS)
- Rep. Davis, Donald G. [D-NC-1] (D-NC)
- Rep. Fleischmann, Charles J. "Chuck" [R-TN-3] (R-TN)
- Rep. Gottheimer, Josh [D-NJ-5] (D-NJ)
- Rep. Griffith, H. Morgan [R-VA-9] (R-VA)
- Rep. Hayes, Jahana [D-CT-5] (D-CT)
- Rep. Joyce, John [R-PA-13] (R-PA)
- Rep. Kean, Thomas H. [R-NJ-7] (R-NJ)
- Rep. Keating, William R. [D-MA-9] (D-MA)
- Rep. Kelly, Trent [R-MS-1] (R-MS)
- Rep. Kiggans, Jennifer A. [R-VA-2] (R-VA)
- Rep. LaLota, Nick [R-NY-1] (R-NY)
- Rep. LaMalfa, Doug [R-CA-1] (R-CA)
- Rep. Magaziner, Seth [D-RI-2] (D-RI)
- Rep. McCormick, Richard [R-GA-7] (R-GA)
- Rep. McGuire, John J. [R-VA-5] (R-VA)
- Rep. Miller, Carol D. [R-WV-1] (R-WV)
- Rep. Moore, Barry [R-AL-1] (R-AL)
- Rep. Murphy, Gregory F. [R-NC-3] (R-NC)
- Rep. Pingree, Chellie [D-ME-1] (D-ME)
- Rep. Pou, Nellie [D-NJ-9] (D-NJ)
- Rep. Raskin, Jamie [D-MD-8] (D-MD)
- Rep. Rose, John W. [R-TN-6] (R-TN)
- Rep. Rulli, Michael A. [R-OH-6] (R-OH)
- Rep. Schmidt, Derek [R-KS-2] (R-KS)
- Rep. Smith, Christopher H. [R-NJ-4] (R-NJ)
- Rep. Subramanyam, Suhas [D-VA-10] (D-VA)
- Rep. Suozzi, Thomas R. [D-NY-3] (D-NY)
- Rep. Taylor, David J. [R-OH-2] (R-OH)
- Rep. Vindman, Eugene [D-VA-7] (D-VA)
- Rep. Wilson, Joe [R-SC-2] (R-SC)
- Rep. Wittman, Robert J. [R-VA-1] (R-VA)
Money behind the sponsor
Top reported contributors to Jefferson Van Drew’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $176,557
- ENTREPRENEUR $70,972
- PULSE VASCULAR $9,900
- ICONA RESORTS $9,900
- MONZO CATANESE HILLEGASS $9,000
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Jefferson Van Drew → · Outside spending →
Actions (2)
- Feb 10, 2025 Referred to the House Committee on Energy and Commerce. · house
- Feb 10, 2025 Introduced in House
More bills on these subjects (6)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Committee action
What happened to this bill in committee — the meetings where it was considered and every recorded vote taken on it.
Meetings where this bill was on the agenda
Full text
IN THE HOUSE OF REPRESENTATIVES
February 10, 2025
Mr. Van Drew (for himself, Mr. Murphy, Mr. Davis of North Carolina, Mr. Balderson, Mr. Carter of Texas, Mr. LaMalfa, Mr. Griffith, Mr. Magaziner, Mr. Moore of Alabama, Ms. Norton, Mr. Rulli, Mr. Cline, Mr. Wittman, Mrs. Cherfilus-McCormick, and Mr. Smith of New Jersey) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to add alpha-gal to the definition of “major food allergen”.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Alpha-gal Allergen Inclusion Act”.
SEC. 2. ADDING ALPHA-GAL TO DEFINITION OF “MAJOR FOOD ALLERGEN”.
(a) In General.—Section 201(qq) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(qq)) is amended by adding at the end the following:
“(3)(A) Galactose-alpha-1,3-galactose (commonly known as ‘alpha-gal’).
“(B) For purposes of this subparagraph, the term ‘galactose-alpha-1,3-galactose’ includes—
“(i) ingredients derived from non-catarrhine primate mammals; and
“(ii) red algae in the order Gigartinales.
“(C) For purposes of this subparagraph, the term ‘galactose-alpha-1,3-galactose’ does not include mammal-derived ingredients for which the Secretary determines there is no galactose-alpha-1,3-galactose above an established, detectable limit (such as ingredients made from alpha-gal-knockout mammals).”.
(b) Effective Date.—The amendment made by subsection (a) shall apply beginning on the date that is 18 months after the date of enactment of this Act. <all>
Comments